Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report

NCT04623437 is registered in ClinicalTrials.gov with University Hospital Sestre Milosrdnice as lead sponsor.

NCT NCT04623437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04623437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report
Lead sponsor
University Hospital Sestre Milosrdnice
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
September 5, 2017
Enrollment
267 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastic treatment, oncology, pharmacovigilance